Churchill Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.79M | Sell |
21,996
-4,392
| -17% | -$1.96M | 0.11% | 75 |
|
|
2025
Q1 | $12.8M | Sell |
26,388
-19,069
| -42% | -$9.24M | 0.16% | 51 |
|
|
2024
Q4 | $18.3M | Buy |
45,457
+102
| +0.2% | +$41.1K | 0.2% | 35 |
|
|
2024
Q3 | $21.1M | Sell |
45,355
-501
| -1% | -$233K | 0.24% | 36 |
|
|
2024
Q2 | $21.5M | Sell |
45,856
-320
| -0.7% | -$150K | 0.25% | 34 |
|
|
2024
Q1 | $19.3M | Sell |
46,176
-368
| -0.8% | -$154K | 0.24% | 38 |
|
|
2023
Q4 | $18.9M | Sell |
46,544
-2,317
| -5% | -$943K | 0.29% | 30 |
|
|
2023
Q3 | $17M | Sell |
48,861
-1,540
| -3% | -$536K | 0.29% | 33 |
|
|
2023
Q2 | $17.7M | Sell |
50,401
-2,557
| -5% | -$900K | 0.3% | 32 |
|
|
2023
Q1 | $16.7M | Sell |
52,958
-2,216
| -4% | -$698K | 0.34% | 30 |
|
|
2022
Q4 | $15.9M | Buy |
55,174
+47,196
| +592% | +$13.6M | 0.39% | 30 |
|
|
2022
Q3 | $2.31M | Buy |
7,978
+43
| +0.5% | +$12.5K | 0.06% | 104 |
|
|
2022
Q2 | $2.24M | Buy |
7,935
+42
| +0.5% | +$11.8K | 0.06% | 109 |
|
|
2022
Q1 | $2.06M | Buy |
7,893
+345
| +5% | +$90K | 0.04% | 117 |
|
|
2021
Q4 | $1.66M | Buy |
+7,548
| New | +$1.66M | 0.02% | 137 |
|
|
2020
Q4 | – | Sell |
-9,905
| Closed | -$2.7M | – | 151 |
|
|
2020
Q3 | $2.7M | Buy |
9,905
+4,890
| +98% | +$1.33M | 0.07% | 106 |
|
|
2020
Q2 | $1.46M | Buy |
+5,015
| New | +$1.46M | 0.05% | 94 |
|
|
2020
Q1 | – | Sell |
-104,350
| Closed | -$22.8M | – | 131 |
|
|
2019
Q4 | $22.8M | Buy |
+104,350
| New | +$22.8M | 0.43% | 23 |
|
|
2018
Q4 | – | Sell |
-158,165
| Closed | -$30.5M | – | 148 |
|
|
2018
Q3 | $30.5M | Buy |
+158,165
| New | +$30.5M | 0.66% | 20 |
|